Kamyar Hadian

5.8k total citations · 4 hit papers
78 papers, 4.2k citations indexed

About

Kamyar Hadian is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kamyar Hadian has authored 78 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kamyar Hadian's work include RNA modifications and cancer (11 papers), Ubiquitin and proteasome pathways (10 papers) and Ferroptosis and cancer prognosis (9 papers). Kamyar Hadian is often cited by papers focused on RNA modifications and cancer (11 papers), Ubiquitin and proteasome pathways (10 papers) and Ferroptosis and cancer prognosis (9 papers). Kamyar Hadian collaborates with scholars based in Germany, United States and United Kingdom. Kamyar Hadian's co-authors include Brent R. Stockwell, Kenji Schorpp, Daniel Krappmann, Ina Rothenaigner, Nataša Anastasov, Stefanie M. Hauck, Sebastian Brandner, Philippe Schmitt‐Kopplin, Constanze Müller and Fereshteh Zandkarimi and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Kamyar Hadian

75 papers receiving 4.2k citations

Hit Papers

GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferro... 2019 2026 2021 2023 2019 2020 2020 2023 250 500 750

Peers

Kamyar Hadian
Kellen Olszewski United States
Liwen Xu China
Sunmin Lee United States
Adrie van Bokhoven United States
Clifford G. Tepper United States
Yuan Fang China
Kellen Olszewski United States
Kamyar Hadian
Citations per year, relative to Kamyar Hadian Kamyar Hadian (= 1×) peers Kellen Olszewski

Countries citing papers authored by Kamyar Hadian

Since Specialization
Citations

This map shows the geographic impact of Kamyar Hadian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamyar Hadian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamyar Hadian more than expected).

Fields of papers citing papers by Kamyar Hadian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamyar Hadian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamyar Hadian. The network helps show where Kamyar Hadian may publish in the future.

Co-authorship network of co-authors of Kamyar Hadian

This figure shows the co-authorship network connecting the top 25 collaborators of Kamyar Hadian. A scholar is included among the top collaborators of Kamyar Hadian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamyar Hadian. Kamyar Hadian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nair, Vidya Padmanabhan, Gabriele Ciceri, Ina Rothenaigner, et al.. (2024). Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development. Nature Communications. 15(1). 7611–7611. 23 indexed citations
2.
Tonnus, Wulf, Francesca Maremonti, Mami Sato, et al.. (2024). Seratrodast inhibits ferroptosis by suppressing lipid peroxidation. Cell Death and Disease. 15(11). 853–853. 6 indexed citations
3.
Yang, Xiaohua, Ina Rothenaigner, Marina Bullo, et al.. (2024). Cyclosporine A in children with ABCA3 deficiency. Pediatric Pulmonology. 59(12). 3221–3227. 2 indexed citations
4.
Schorpp, Kenji, Howard Junca, Mathias Müsken, et al.. (2024). Screening Privileged Alkyl Guanidinium Motifs under Host-Mimicking Conditions Reveals a Novel Antibiotic with an Unconventional Mode of Action. SHILAP Revista de lepidopterología. 4(8). 3125–3134. 1 indexed citations
5.
Yang, Xiaohua, Christina Rapp, Ina Rothenaigner, et al.. (2023). ABCA3 Deficiency—Variant-Specific Response to Hydroxychloroquine. International Journal of Molecular Sciences. 24(9). 8179–8179. 5 indexed citations
6.
Rothenaigner, Ina, et al.. (2022). High-content screen identifies cyclosporin A as a novel ABCA3-specific molecular corrector. Klinische Pädiatrie. 234(5). 344–345.
7.
Koch, Uwe, et al.. (2021). Highly Accurate Filters to Flag Frequent Hitters in AlphaScreen Assays by Suggesting their Mechanism. Molecular Informatics. 41(3). e2100151–e2100151. 2 indexed citations
8.
Dahlin, Jayme L., Douglas S. Auld, Ina Rothenaigner, et al.. (2021). Nuisance compounds in cellular assays. Cell chemical biology. 28(3). 356–370. 33 indexed citations
9.
Paulus, Christina, Hans Stubbe, Maryam Karimi, et al.. (2020). Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers. mBio. 11(2). 24 indexed citations
10.
Jagtap, Pravin Kumar Ankush, Komal Soni, Cindy L. Will, et al.. (2020). Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly. Nature Communications. 11(1). 5621–5621. 26 indexed citations
11.
Dawidowski, Maciej, Kenji Schorpp, Leonidas Emmanouilidis, et al.. (2019). Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity. Journal of Medicinal Chemistry. 63(2). 847–879. 15 indexed citations
12.
Schorpp, Kenji, et al.. (2018). A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor. Journal of Biological Chemistry. 293(23). 8994–9005. 2 indexed citations
13.
Keminer, Oliver, et al.. (2017). A high-content small molecule screen identifies novel inducers of definitive endoderm. Molecular Metabolism. 6(7). 640–650. 27 indexed citations
14.
Dawidowski, Maciej, Leonidas Emmanouilidis, Konstantinos Tripsianes, et al.. (2017). Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites. Science. 355(6332). 1416–1420. 45 indexed citations
15.
Schorpp, Kenji, et al.. (2017). Innovative therapeutic modalities for solid EpCAM-positive tumours. FEBS Journal. 1 indexed citations
16.
Höfig, Ines, Michael Rosemann, Sabine Richter, et al.. (2016). Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer. Cancer Medicine. 5(4). 703–710. 22 indexed citations
17.
Diener, Susanne, Kenji Schorpp, Tim-Matthias Strom, Kamyar Hadian, & Bettina Lorenz‐Depiereux. (2015). Development of A Cell-Based Assay to Identify Small Molecule Inhibitors of FGF23 Signaling. Assay and Drug Development Technologies. 13(8). 476–487. 4 indexed citations
18.
Schorpp, Kenji & Kamyar Hadian. (2014). Small molecule Screening at Helmholtz Zentrum München – From Biology to Molecules. Combinatorial Chemistry & High Throughput Screening. 17(3). 266–271. 5 indexed citations
19.
Vincendeau, Michelle, Daniel Nagel, Jara Kerstin Brenke, Ruth Brack‐Werner, & Kamyar Hadian. (2013). Heterogenous nuclear ribonucleoprotein Q increases protein expression from HIV-1 Rev-dependent transcripts. Virology Journal. 10(1). 151–151. 11 indexed citations
20.
Nagel, Daniel, Stefani Spranger, Michelle Vincendeau, et al.. (2012). Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL. Cancer Cell. 22(6). 825–837. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026